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SCU protecting against myocardial injury induced by ischemia reperfusion (IR) are
not well known. This study examined whether SCU protects against myocardial IR
injury is mediated by the Janus kinase and signal transducer and activator of tran-
scription (JAK/STAT) pathway.
Methods: Three models were used: a rat model of myocardial IR, an isolated thoracic
artery (TA) hypoxia reoxygenation (HR) model, and a human cardiac microvascular
endothelial cell (HCMEC) HR model. Protein and mRNA expression of JAK2/STAT3
and phosphorylative products were assessed by Western blot, immunohistochemistry
and RT-PCR method.
Results: In the rat myocardial IR model, SCU (45 and 90 mg/kg, iv) signiﬁcantly
reduced ischemic size, while immunohistochemical results showed that SCU signiﬁ-
cantly decreased histological phosphorylation JAK2 (P-JAK2) and STAT3 (P-
STAT3) expression. In isolated TA rings, pre-incubation with SCU (100, 500 mmol/
L) signiﬁcantly inhibited JAK2/STAT3 expression after HR. Western blot and RT-
PCR of HCMECs indicated that SCU (0.1, 1.0, 10 mmol/L) incubations signiﬁcantly
inhibited the phosphorylation of JAK2 and its downstream molecule STAT3 and in
contrast, HR up-regulated them.
Conclusions: SCU attenuates myocardial IR injury, at least in part, by inhibiting
injury-induced activation of JAK2/STAT3 signaling pathway.
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Objectives: Mitochondrial connexin 43 (Cx43) plays an essential role in ischemic
preconditioning cardioprotection, however, it remains unclear whether mitochondrial
Cx43 is involved in mitochondrial dysfunction in the pathogenesis of dilated car-
diomyopathy (DCM). The present study was performed in order to investigate the
changes of the expression and phosphorylation state of mitochondrial Cx43 in a rat
model of DCM and to determine whether the altered mitochondrial Cx43 phosphor-
ylation state was involved in mitochondrial dysfunction.
Methods: The rat model of DCM was generated by daily oral administration of
furazolidone (FZD) for 30 weeks and was identiﬁed by echocardiographic studies.
The expression and phosphorylation state of mitochondrial Cx43 were examined by
western blot. The expression and activity of protein kinase C (PKC) ε were also
analyzed by western blot to reveal the underlying mechanism of Cx43 dephosphor-
ylation at serine 368. And then, the mitochondrial membrane potential level was
assessed using JC-1 by quantitative ﬂuorescence measurement. The activities of
cytochrome c oxidase and succinate dehydrogenase were determined by quantitative
colorimetric assay kit. The primary cultured neonatal rat cardiomyocytes were
sparsely plated without cell to cell contact and incubated with 100 nmmol/L phorbol-
12-myristate-13-acetate (PMA, a speciﬁc PKC activator) for 60 min after 48 h
FZD treatment to assess the effects of PKC activation on the FZD-induced mito-
chondrial Cx43 dephosphorylation and mitochondrial dysfunction. Pretreatment with
18b-glycerrhetinic acid (GA, a connexin channels inhibitor) for 4 h was performed to
determine the impact of mtCx43 suppression on PKC-activator induced mitochondrial
protection in the FZD-treated cardiomyocytes.
Results: Real-time PCR and western blot revealed the decreased expression of overall
Cx43 accompanied with lower level of serine 368-phosphorylated Cx43 immunoreac-
tivity in the myocardium and myocardial mitochondria. Meantime, mitochondrial mem-
brane potential level and the activities of cytochrome c oxidase, succinate dehydrogenase
and PKCεwere all reduced. PMApartially reversed theFZD-inducedmitochondrialCx43
dephosphorylation serine S368 and themitochondrial dysfunction in the cardiomyocytes.
However, pretreatment with GA abolished the mitochondrial protective effect of PMA in
the cardiomyocytes sparsely plated without cell to cell contact.
Conclusions: Our results suggest that mitochondrial Cx43 dephosphorylation at
serine 368 due to the suppression of PKCε activity may be a novel mechanism for
mitochondrial dysfunction in the pathogenesis of DCM.
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Objectives: Human cytomegalovirus (HCMV) infection is associated with cardio-
vascular diseases, especially atherosclerosis. The detailed mechanisms were not fully
understood yet. Vascular endothelial cell injury has been suggested playing a key role
in the initiation and progression of atherosclerosis. This study is aiming to determine
whether HCMV infection can induce apoptosis in human umbilical vein endothelial
cells (HUVEC) via the Fas/FasL pathway, and lead to endothelial cell injury in vitro.
Methods: HUVEC were isolated and cultrured in vitro. DAPI staining method was
used to investigate the morphology of apoptotic HUVEC cells, and ﬂow cytometry
(FCM) to quantitatively detect the apoptotic rate. An antagonistic anti-Fas antibody
was applied to block apoptosis. The transcription of Fas mRNA in the HUVEC cells
infected by HCMV AD169 strain and corresponding cells were detected with RT-PCR
method. The expression of Fas was detected by FCM using FITC-conjugated
monoclonal antibody.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BResults: Chromatin condensation and marginalization were found in HUVEC cells
infected with HCMV at 48 h and karyorrhexis started presenting in some cells, which
became more remarkable at 96 h. The apoptosis rates of HUVEC cells were 21.37%
and 55.83% at 48 h and 96 h, respectively, which were decreased to 8.26% and
17.65% after the cells were pretreated with the anti-Fas antibody. The transcriptional
level of Fas mRNA in HUVEC cells infected with HCMV AD169 strain showed a
strong uptrend over time compared with corresponding cells. Fas expression rates of
HUVEC cells rose up to 69.47% and 81.59%, respectively, compared with that of
10.35% and 13.67% in control groups at 48 h and 96 h.
Conclusions: HCMV AD169 strain can up-regulate Fas expression levels of HUVEC
cells and induce apoptosis of cells via Fas/FasL pathway. These results suggest that
Fas/FasL pathway may play a role in vascular endothelial cell injury and ultimately
lead to atherosclerosis.
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Objectives: G protein-coupled receptor kinase 4 (GRK4) gene variants, via impair-
ment of renal dopamine receptor and enhancement of renin-angiotensin system
functions, cause sodium retention and increase blood pressure. Whether or not GRK4
and the angiotensin type 1 receptor (AT1R) interact in the aorta is not known.
Methods: GRK4 expression in vascular smooth muscle cells (VSMCs) of the aorta
was analyzed by confocal microscopy of double-stained, RT-PCR and immunoblot-
ting. AT1R protein expression and function in GRK4 variant 142V transfected A10
cells and WT cells was quantiﬁed by immunoblotting and AT1R-mediated intracel-
lular calcium concentration. AT1R phosphorylation level was determined by immu-
noprecipitation. The interaction between GRK4 and AT1R was determined by
immunoprecipitation and confocal microscopy of double-stained. NF-kB activity was
analyzed by electrophoretic mobility shift assay (EMSA). Angiotensin II-mediated
vasoconstriction of the aorta from 142V-transgentic mice and WT mcie was analyzed
by tension measurement of the artery rings.
Results:We report that GRK4 is expressed in vascular smooth muscle cells (VSMCs)
of the aorta. Heterologous expression of the GRK4g variant 142V in A10 cells
increased AT1R protein expression and AT1R-mediated increase in intracellular cal-
cium concentration. The increase in AT1R expression was related to an increase in
AT1R mRNA expression via the NF-kB pathway. As compared with control, cells
expressing GRK4g 142V had greater NF-kB activity with more NF-kB bound to the
AT1R promoter. The increased AT1R expression in cells expressing GRK4g 142V
was also associated with decreased AT1R degradation, which may be ascribed to
lower AT1R phosphorylation. There was a direct interaction between GRK4g wild-
type (WT) and AT1R that was decreased by GRK4g 142V. The regulation of AT1R
expression by GRK4g 142V in A10 cells was conﬁrmed in GRK4g 142V transgenic
mice; AT1R expression was higher in the aorta of GRK4g 142V transgenic mice than
control GRK4g wild-type (WT) mice. Angiotensin II-mediated vasoconstriction of the
aorta was also higher in GRK4g 142V than WT transgenic mice.
Conclusions: This study provides a mechanism by which GRK4, via regulation of
arterial AT1R expression and function, participates in the pathogenesis of conduit
vessel abnormalities in hypertension.
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Objectives: Ischemia reperfusion induces a high percentage of lethal arrhythmias.
Sirtuin 3 (SIRT3), a key nutrient sensing regulator by governing mitochondrial ho-
meostasis, was also reported to protect heart from reactive oxygen species (ROS)
assaults, but whether it is involved in ischemia reperfusion arrhythmias (IRA) and the
mechanism underlying remains unknown.
Methods: Sirt3 knockout (SIRT3 KO) mice and littermate wild-type (WT) mice were
assigned into sham group, ischemia reperfusion group (I/R) and I/R with NAD treated
group (7 days, 1 mg/kg/day) (NAD+I/R). Electrocardiography (ECG) was recorded
during I/R for arrhythmia score assessment, and cardiac reactive oxygen species
(ROS) production, SIRT3 and MnSOD levels were measured and analyzed.
Results: The results revealed that arrhythmia could be detected in sham SIRT3 KO
mice, and more serious arrhythmia was triggered by I/R in SIRT3 KO mice than WT
mice (P<0.05). Moreover, SIRT3 KO mice showed increased ROS production after
I/R compared with WT I/R mice (P<0.05), which was in accordance with decreased
manganese superoxide dismutase (MnSOD) and catalase (Cat) expression. NAD
treatment signiﬁcantly increased cardiac SIRT3 and MnSOD activity, inhibited ROS
production, and consequently suppressed IRA in WT mice, but failed in SIRT3 KO
mice.
Conclusions: These ﬁndings indicated that impairment of SIRT3 expression with
subsequent ROS production played an important role in IRA. Therefore, preserving
SIRT3 activity could be a potential approach to prevent IRA.asic and Translational Medicine C29
